Jpmorgan Chase & Co »

Conduit Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Conduit Pharmaceuticals (CDT) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Conduit Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Conduit Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Conduit Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.6k 22k 0.12
2024-06-30 $10k 9.8k 1.06
2024-03-31 $99k 27k 3.67
2023-12-31 $29k 6.4k 4.55